Advances in Borderline Resectable Pancreatic Adenocarcinoma

Abstract: Pancreatic adenocarcinoma is one of the most lethal cancers in oncology. Pancreatic cancer is the third most common cause of cancer-related mortality in the United […]

The Role of PARP Inhibitors in Germline BRCA-Associated Pancreatic Ductal Adenocarcinoma

Abstract: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy that remains a challenge to treat. In pursuit of personalized medicine, researchers continue active exploration of […]

Second-Line Treatment for Metastatic Pancreatic Cancer

Abstract: Pancreatic cancer is the fourth-leading cause of cancer-related death. It is commonly diagnosed at an advanced stage, when no curative options exist. Over the […]

Adjuvant Treatment of Surgically Resectable Pancreatic Ductal Adenocarcinoma

Abstract: Pancreatic ductal adenocarcinoma (PDAC) is the third-leading cause of cancer-related mortality in the United States. Surgical resection of early and localized disease provides the […]

Evolving Standards of Care for Resected Pancreatic Cancer

Abstract: Pancreatic cancer is a devastating illness, and surgical resection offers the only chance of a cure for patients with the disease. Relatively few […]